Advertisement

Advertisement

SXTP Stock Latest News

60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions

Company Announcements60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions

60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital

PremiumCompany Announcements

60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital

10d ago

60 Degrees Pharmaceuticals to sell shares and warrants in private placement

PremiumThe Fly

60 Degrees Pharmaceuticals to sell shares and warrants in private placement

15d ago

60 Degrees Pharma babesiosis interim readout planned by October 6

PremiumThe Fly

60 Degrees Pharma babesiosis interim readout planned by October 6

16d ago

60 Degrees updates strategy for ARAKODA and profitability

PremiumCompany Announcements

60 Degrees updates strategy for ARAKODA and profitability

25d ago

Interim Trial Plan Finalized for Tafenoquine Babesiosis Study

PremiumCompany AnnouncementsInterim Trial Plan Finalized for Tafenoquine Babesiosis Study

1M ago

60 Degrees Pharmaceuticals signs option deal with Florida State University

The Fly

60 Degrees Pharmaceuticals signs option deal with Florida State University

1M ago

60 Degrees Pharmaceuticals announces DSMB recommendation for B-Free study

The Fly

60 Degrees Pharmaceuticals announces DSMB recommendation for B-Free study

1M ago

60 Degrees executes patent licensing agreement with Florida State

PremiumThe Fly

60 Degrees executes patent licensing agreement with Florida State

2M ago

60 Degrees details tafenoquine priority review voucher strategy

PremiumCompany Announcements

60 Degrees details tafenoquine priority review voucher strategy

2M ago

60 Degrees announces early enrollment of first patient in trial of tafenoquine

PremiumThe Fly

60 Degrees announces early enrollment of first patient in trial of tafenoquine

3M ago

H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

PremiumThe Fly

H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

3M ago

60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

PremiumThe Fly60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

3M ago

60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

The Fly

60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

4M ago

SXTP Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

SXTP Earnings Report this Week: Is It a Buy, Ahead of Earnings?

5M ago

60 Degrees Updates Affiliate Share Ownership Disclosure Error

PremiumCompany Announcements

60 Degrees Updates Affiliate Share Ownership Disclosure Error

5M ago

60 Degrees submits NDIN to FDA for Australian Chestnut Extract

PremiumThe Fly

60 Degrees submits NDIN to FDA for Australian Chestnut Extract

5M ago

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

PremiumCompany Announcements

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

5M ago

60 Degrees Pharmaceuticals Updates Opinion for ATM Program

PremiumCompany Announcements

60 Degrees Pharmaceuticals Updates Opinion for ATM Program

5M ago

60 Degrees reports all patients cured of babesiosis after tafenoquine treatment

PremiumThe Fly60 Degrees reports all patients cured of babesiosis after tafenoquine treatment

5M ago

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

Company Announcements

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

6M ago

60 Degrees expands access to Arakoda with GoodRx partnership

The Fly

60 Degrees expands access to Arakoda with GoodRx partnership

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >